Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125865842 | 12586584 | 2 | F | 20160604 | 20160906 | 20160725 | 20160922 | PER | US-PFIZER INC-2016326959 | PFIZER | 71.00 | YR | M | Y | 88.00000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125865842 | 12586584 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, UNK | Y | 20702 | 20 | MG | FILM-COATED TABLET | ||||||
125865842 | 12586584 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | TWO HALVES OF A SPLIT 40 MG TABLET ONCE DAILY | Y | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
125865842 | 12586584 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, UNK | Y | 20702 | 20 | MG | FILM-COATED TABLET | |||||||
125865842 | 12586584 | 4 | SS | LOSARTAN. | LOSARTAN | 1 | Oral | 1/2 OF A 100 MG PILL ONCE DAILY | 0 | 50 | MG | QD | |||||||
125865842 | 12586584 | 5 | SS | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
125865842 | 12586584 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK, AS NEEDED | 0 | |||||||||||
125865842 | 12586584 | 7 | C | MELOXICAM. | MELOXICAM | 1 | UNK, AS NEEDED | 0 | |||||||||||
125865842 | 12586584 | 8 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK, DAILY | 0 | |||||||||||
125865842 | 12586584 | 9 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, DAILY | 0 | 81 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125865842 | 12586584 | 1 | Blood cholesterol abnormal |
125865842 | 12586584 | 2 | Blood cholesterol increased |
125865842 | 12586584 | 4 | Blood pressure management |
125865842 | 12586584 | 5 | Hypertension |
125865842 | 12586584 | 6 | Anxiety |
125865842 | 12586584 | 7 | Arthritis |
125865842 | 12586584 | 8 | Hypersensitivity |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125865842 | 12586584 | Arthritis | |
125865842 | 12586584 | Asthenia | |
125865842 | 12586584 | Condition aggravated | |
125865842 | 12586584 | Fatigue | |
125865842 | 12586584 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125865842 | 12586584 | 2 | 201606 | 0 |